208 related articles for article (PubMed ID: 9475148)
1. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
[TBL] [Abstract][Full Text] [Related]
2. Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
Kohorn EI
J Reprod Med; 1998 Jan; 43(1):33-6. PubMed ID: 9475147
[TBL] [Abstract][Full Text] [Related]
3. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
4. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors and staging in gestational trophoblastic tumor.
Soper JT; Evans AC; Conaway MR; Clarke-Pearson DL; Berchuck A; Hammond CB
Obstet Gynecol; 1994 Dec; 84(6):969-73. PubMed ID: 7970479
[TBL] [Abstract][Full Text] [Related]
7. Classification and staging of gestational trophoblastic tumors.
Miller DS; Lurain JR
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):477-90. PubMed ID: 2852330
[TBL] [Abstract][Full Text] [Related]
8. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
Ayhan A; Yapar EG; Deren O; Kişnişçi H
J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
[TBL] [Abstract][Full Text] [Related]
9. Treatment of gestational trophoblastic neoplasia according to the FIGO 2000 staging and scoring system: a 20 years' experience.
Wang KL; Yang YC; Wang TY; Cheng-Yen Lai J; Chen TC; Chang CL
Acta Obstet Gynecol Scand; 2009; 88(2):204-8. PubMed ID: 19031297
[TBL] [Abstract][Full Text] [Related]
10. [Gestational trophoblastic tumors and recent clinical information].
Shimizu T; Yaegashi N
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
[TBL] [Abstract][Full Text] [Related]
12. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
[TBL] [Abstract][Full Text] [Related]
13. Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.
El-Helw LM; Coleman RE; Everard JE; Tidy JA; Horsman JM; Elkhenini HF; Hancock BW
Gynecol Oncol; 2009 Jun; 113(3):306-11. PubMed ID: 19269684
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
[TBL] [Abstract][Full Text] [Related]
16. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.
Kohorn EI
J Reprod Med; 2002 Jun; 47(6):445-50. PubMed ID: 12092012
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
18. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Wan XR; Sun ZJ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
[TBL] [Abstract][Full Text] [Related]
19. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
20. Problems with nomenclature and pharmacodynamics in trophoblastic disease.
Kohorn EI
J Clin Oncol; 2004 Jan; 22(1):203-4; author reply 204. PubMed ID: 14701788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
